SECURITIES AND EXCHANGE COMMISSION
                                 WASHINGTON, DC

                                    FORM 10-Q/A

(Mark One)

  X  Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange
 --- Act of 1934

                  For the quarterly period ended June 30, 1999
                                                 -------------
                                       or

 ---   Transition Report Pursuant to Section 13 or 15(d) of the Securities
             Exchange Act of 1934

                For the transition period from _______ to _______

                         Commission File Number: 0-28748
                                                 -------
                           CLOSURE MEDICAL CORPORATION
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)



          Delaware                                     56-1959623
----------------------------                        ------------------
(State or other jurisdiction                        (I.R.S. Employer
     of incorporation or                            Identification No.)
        organization)



              5250 Greens Dairy Road, Raleigh, North Carolina 27616
              -----------------------------------------------------
               (Address of principal executive offices) (Zip Code)

                                 (919) 876-7800
              -----------------------------------------------------
              (Registrant's telephone number, including area code)


         Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

         Yes [X]                                                      No [ ]

         Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practicable date.


          Class                                   Outstanding at August 11, 1999
          -----                                   ------------------------------
Common Stock, par value $0.01 per share                          13,334,251

<PAGE>

                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                             CLOSURE MEDICAL CORPORATION



Date: August 19, 1999     By:\s\ Robert V. Toni
                             --------------------
                                   Robert V. Toni
                                   President and Chief Executive Officer



Date: August 19, 1999      By:\s\ J. Blount Swain
                             --------------------
                                   J. Blount Swain
                                   Vice President and Chief Financial Officer
                                   (Principal Financial and Accounting Officer)